Skip to content

About
Careers
News & Blog
Contact

Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases

September 7, 2023 |

Otsuka collaborates with Shape^TX to develop novel AAV gene therapies for ocular diseases

More Posts

Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases

How AI will revolutionize drug discovery: ShapeTX CEO Francois Vigneault on Tech Nation

Spotlight Video: Solving puzzles as a team

The future of programmable RNA medicine

About Careers News & Blog Contact

Seattle

700 Dexter Ave N
Seattle, WA 98109

Boston

17 Drydock Ave
Boston, MA 02210

© 2023 Shape TX

Privacy Policy

© 2023 ShapeTX • Built with GeneratePress

The future of programmable RNA medicine

About
Careers
News & Blog
Contact

Otsuka collaborates with Shape^TX to develop novel AAV gene therapies for ocular diseases